Search

Xencor Inc

Закрыт

СекторЗдравоохранение

26.58 0.57

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

26.58

Макс.

26.73

Ключевые показатели

By Trading Economics

Доход

107M

-22M

Продажи

47M

51M

Прибыль на акцию

-0.29

Рентабельность продаж

-42.422

Сотрудники

260

EBITDA

109M

-12M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+16.5% upside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

589M

2B

Предыдущая цена открытия

26.01

Предыдущая цена закрытия

26.58

Новостные настроения

By Acuity

50%

50%

131 / 339 Рейтинг в Healthcare

Xencor Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 сент. 2026 г., 20:07 UTC

Xencor Inc shares are higher, recovering from earlier losses amid broader market selling pressure following a strong jobs report. No specific news was identified.

3 сент. 2026 г., 22:15 UTC

News

Shares lower in after-market trading after JP Morgan's rating.

2 сент. 2026 г., 20:08 UTC

Xencor Inc shares are lower today, reversing from an early gain amid a weaker-than-expected ADP employment report affecting investor sentiment on interest rates.

1 сент. 2026 г., 23:01 UTC

Xencor Inc shares are lower in after-market hours, with no specific news identified. This decline occurs amid broader market concerns over economic growth data.

31 авг. 2026 г., 20:03 UTC

Xencor Inc shares are higher today, supported by strong trading volume. The stock is above its 20-day moving average and near its one-month range high.

28 авг. 2026 г., 20:02 UTC

Xencor Inc shares are lower today, breaking a trend of higher closes. The decline occurs amid rising U.S. Treasury yields and high trading volume.

27 авг. 2026 г., 20:07 UTC

Xencor Inc shares are higher today, recovering from an early dip. The stock is trading well above its 20-day moving average.

26 авг. 2026 г., 23:01 UTC

Xencor Inc shares are lower in after-market trading amid overall market declines. No specific news was identified to explain the stock's movement.

25 авг. 2026 г., 19:36 UTC

Xencor Inc shares are higher, supported by declining crude oil prices and lower Treasury yields. The stock remains above its 20-day moving average.

24 авг. 2026 г., 19:46 UTC

Xencor Inc's shares are higher Monday, rebounding from an earlier low amid rising oil prices and geopolitical tensions, despite no specific company news.

21 авг. 2026 г., 21:41 UTC

Xencor Inc shares are higher in after-market trading, following a recent trend that shows a 44% increase over the past month.

20 авг. 2026 г., 19:56 UTC

Correlated Moves

Xencor Inc shares declined during Thursday's session amid broader sector weakness, influenced by negative sentiment following Walmart's disappointing earnings report.

19 авг. 2026 г., 20:03 UTC

Xencor Inc shares are higher during Wednesday's session, driven by strong market performance and high trading volume. No specific news was identified to explain the move.

18 авг. 2026 г., 20:03 UTC

Xencor Inc shares are trading higher today, supported by strong upward momentum and unusually high market volume. No specific news was identified for the movement.

17 авг. 2026 г., 19:26 UTC

Social Media

Xencor Inc shares are lower despite increased institutional interest, including Johnson & Johnson's $12 million acquisition of 748,062 shares.

14 авг. 2026 г., 19:16 UTC

Shares of Xencor Inc. are modestly higher amid cautious broader market sentiment following a decline in U.S. retail sales for July.

13 авг. 2026 г., 19:21 UTC

Xencor Inc shares are lower today, with no specific news driving the decline. High trading volume suggests increased activity amid routine fluctuations.

12 авг. 2026 г., 19:56 UTC

Social Media

Xencor Inc shares are higher, supported by social media discussions valuing the company at $1.3 billion based on its ENPP3 asset potential.

11 авг. 2026 г., 19:26 UTC

Xencor Inc shares are advancing, continuing a four-session trend. Investors are focused on upcoming inflation reports that may influence market sentiment.

10 авг. 2026 г., 19:31 UTC

News

Xencor Inc shares are higher today, buoyed by increased institutional investments from Dimensional Fund Advisors and BVF Inc. IL.

7 авг. 2026 г., 23:16 UTC

Xencor Inc shares are higher in after-market trading, supported by decreased interest rate hike expectations following a Labor Department report on non-farm payrolls.

6 авг. 2026 г., 20:03 UTC

News

Xencor shares are higher as Cantor Fitzgerald raises its price target to $44, reflecting confidence in the company's pipeline and upcoming ESMO Congress presentation.

3 авг. 2026 г., 19:51 UTC

Xencor Inc's shares are declining, continuing a downward trend since Friday's close, despite a broader market rally in technology and airlines.

31 июл. 2026 г., 20:03 UTC

Xencor Inc shares are lower, reversing earlier gains amid rising US Treasury yields and crude oil prices, contributing to inflation concerns and interest rate expectations.

30 июл. 2026 г., 19:03 UTC

News
Social Media

Xencor Inc. gains following a $105 million settlement with Alexion, boosting investor confidence and extending its operating runway through 2028.

29 июл. 2026 г., 19:36 UTC

Xencor Inc. shares are lower as broader market trends decline ahead of the Federal Reserve's policy announcement, amid rising oil prices and inflation concerns.

28 июл. 2026 г., 20:07 UTC

Xencor Inc is gaining amid a strong Biotechnology sector, despite earlier declines. The stock has rebounded to settle near the upper end of its one-month range.

27 июл. 2026 г., 19:11 UTC

Xencor Inc shares are higher today, reflecting a positive market environment despite earlier intraday pullbacks. No specific news was identified to explain the movement.

24 июл. 2026 г., 19:11 UTC

Xencor Inc shares are lower in Friday's session, reflecting broader market trends. No specific news was identified to explain the price movement.

22 июл. 2026 г., 20:06 UTC

Xencor Inc shares are lower today, retracing from an earlier peak. Broader market sentiment is affected by uncertainty ahead of the Federal Reserve meeting.

Сравнение c конкурентами

Изменение цены

Xencor Inc Прогноз

Целевая цена

By TipRanks

16.5% рост

Прогноз на 12 месяцев

Средняя 31 USD  16.5%

Максимум 46 USD

Минимум 20 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Xencor Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

12 ratings

10

Покупка

2

Удержание

0

Продажа

Настроения

By Acuity

131 / 339Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design XmAb technologies and develop candidates with properties. Its antibody design is focused on the segment of antibodies that interact with target antigens. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Vibecotamab, Tidutamab, XmAb841, XmAb104, XmAb306, XmAb104, XmAb564 and XmAb698.
help-icon Live chat